Jane Street’s Impax Laboratories, Inc. IPXL Stock Holding History

Jane Street’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-60,306	Closed	-$1M	–	5797
2017 Q4	$1M	Buy	+60,306	New	+$1.11M	﹤0.01%	2339
2015 Q4	–	Sell	-8,396	Closed	-$296K	–	4731
2015 Q3	$296K	Buy	8,396 +2,317	+38%	+$104K	﹤0.01%	2811
2015 Q2	$279K	Sell	6,079 -4,821	-44%	-$229K	﹤0.01%	2895
2015 Q1	$511K	Buy	10,900 +1,231	+13%	+$49K	﹤0.01%	2037
2014 Q4	$306K	Sell	9,669 -2,608	-21%	-$76.3K	﹤0.01%	1872
2014 Q3	$291K	Buy	+12,277	New	+$314K	﹤0.01%	1914
2014 Q2	–	Sell	-28,139	Closed	-$743K	–	3378
2014 Q1	$743K	Buy	+28,139	New	+$703K	0.01%	1218

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's IPXL Position: Q1 2018 in Review

Jane Street sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 60,306 shares — an estimated $1M sold.

Jane Street first reported a position in IPXL in Q1 2014 and held it in 7 quarters. The position peaked at $1M in Q4 2017. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

Jane Street reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
Jane Street sold 60,306 Impax Laboratories, Inc. shares in Q1 2018, an estimated $1M.
Jane Street first reported a position in Impax Laboratories, Inc. in Q1 2014 and held it in 7 quarters.
Jane Street's Impax Laboratories, Inc. position peaked at $1M in Q4 2017.
188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Jane Street's 13F filing for Q1 2018, filed 15 May 2018.